Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05057455
NCT05057455CompletedNot Applicable

Effectiveness of the Cytokine Hemadsorption on the Clinical Progression and Mortality of Intensive Care Patients With Sepsis

Biruni University1 site in 1 country39 target enrollmentStarted: January 1, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
39
Locations
1
Primary Endpoint
IL-6
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

In this prospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •the patients were the available data of clinical and laboratory diagnosis of sepsis and septic shock
  • •detection of gram-negative bacterial agent in blood or sputum culture.
  • •patients who had the shock symptoms such as hypotension, tachycardia or fever during the course of sepsis.

Exclusion Criteria

  • •had uncontrolled hemorrhage,
  • •diagnosed with cardiac failure at stage 4 or renal failure at stage 4 or hepatic liver failure at stage 4
  • •cancer at the end stage or admitted with acute coronary syndrome.

Outcomes

Primary Outcomes

IL-6

Time Frame: 1 YEARS

levels of IL-6

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Biruni University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

IKUPELI

investigator

Biruni University

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Cytokine Hemadsorption in Covid 19 Patients With Bacterial SepsisINTERLEUKIN 6
NCT04920851Derince Training and Research Hospital23
Recruiting
Not Applicable
Study into the effect of CytoSorb (cytokine adsorber) in relation to the MICrocirculation of patients with Septic Shock and Acute Kidney Injury at the ICU; MICSS-AKI
NL-OMON53033Erasmus Universiteit Rotterdam40
Unknown
Not Applicable
Influence of Thyroid Hormones on the Woundhealing ProcessThyroid NeoplasmsThyroid Carcinoma
NCT00929318Hannover Medical School26
Enrolling By Invitation
Not Applicable
EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTSCytokine Hemadsorption Therapy in Critically Ill Patients Who Have no Microbiological Findings and Develop Vasoplegic Shock
NCT05984407Hakan Küçükkepeci30
Completed
Not Applicable
Adsorbtion of Cytokines Early in Septic Shock: the ACESS StudySepsisSeptic Shock
NCT02288975Zsolt Molnár, MD, PhD, DEAA20